A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
Authors:
- 1 January 2015
- journal article
- research article
- Published by Springer Nature in Hormones
- Vol. 14 (1) , 81-90
Abstract
OBJECTIVE The long-acting glucagon-like peptide 1 receptor agonist liraglutide is linked to progressive and sustained weight loss in obese people with diabetes. However, its efficacy and safety in women with polycystic ovary syndrome (PCOS) has not yet been addressed. DESIGN Thirty-two obese women (aged 27.6±7.2 years, BMI 39.5±6.2 kg/m2) with newly diagnosed PCOS were randomized to receive either liraglutide 1.2 mg QD sc (n=17) or metformin 1000 mg BID po (n=15) for 12 weeks; 28 patients completed the study (14 on liraglutide and 14 on metformin). The main outcome was change in body weight. RESULTS Intention-to-treat analysis showed significant BMI (−0.98 kg/m2; p2 vs. 0.62 kg/m2, respectively). CONCLUSIONS Short-term liraglutide treatment was associated with significant weight loss in a subset of obese patients with newly diagnosed PCOS and a higher metabolic risk profile.Keywords
This publication has 31 references indexed in Scilit:
- Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and ImplicationsEndocrine Reviews, 2012
- Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trialsBMJ, 2012
- Incretin-based Therapies for Type 2 Diabetes—Comparisons Between Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 InhibitorsUS Endocrinology, 2011
- Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndromeThe American Journal of Clinical Nutrition, 2006
- A New Simple Method for the Measurement of Visceral Fat Accumulation by Bioelectrical ImpedanceDiabetes Care, 2005
- Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2003
- Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care, 1999
- Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patientsHuman Reproduction, 1995
- Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndromeClinical Endocrinology, 1992